What we do Sudeep Pharma Limited manufactures excipients and specialty ingredients for pharmaceutical, food, and nutrition industries, focusing on mineral-based products enhancing nutrient absorption and stability. |
Founded in 1,989 |
Market share Leading Indian producer of pharmaceutical excipients and specialty ingredients with growing global presence across 100+ countries and regulatory certifications. |
Problem solved Improves stability, bioavailability, and functionality of pharma and food products with refined mineral ingredients and custom specialty formulations. |
Top clients or who we serve Serves pharmaceutical, food, and nutrition industries globally with 40+ blue-chip MNC clients; focus on B2B markets. |
Key management Chairman & MD Sujit Bhayani (B.Sc Chemistry), Whole Time Director Shanil Bhayani (B.Sc Business Administration), Independent directors from top management backgrounds. |
Our journey and innovations Founded in 1989, pioneered liposomal ingredients in India, expanded product portfolio to 100+ items, developed proprietary technologies, and entered battery materials segment. |
Where we operate India (Vadodara HQ and manufacturing), USA, Europe, and others; exports to ~100 countries with offices in USA and Europe. |
Top products or what we offer Pharmaceutical excipients, mineral fortificants, specialty ingredients like liposomal nutrients, granulated blends, and emerging battery-grade iron phosphate. |
Top brands No explicitly named brands; recognized for high-quality Pharma excipients and specialty nutrient ingredients with US FDA and European certifications. |
Raw materials needed Minerals such as calcium carbonate, iron phosphate, magnesium stearate, and specialty chemicals for formulations. |
Raw materials supplier Not specified, procures from global and domestic suppliers to ensure quality and regulatory compliance. |
Recurring vs cyclical contribution Majority of revenue is recurring, driven by long-term supply contracts and repeat orders in pharmaceutical and nutrition segments. |
Our industry position Market leader in mineral-based pharmaceutical excipients in India, with growing specialty ingredients and expansion into battery materials. |
Financial highlights FY25 consolidated revenue ₹502 Cr; PAT ₹139 Cr; EBITDA margin ~39%; consistent revenue and margin growth over past years. |
Geographical revenue split FY25 revenue split approx. India 40%, USA 19%, Others 41%, indicating a strong export-oriented business model. |
Order book - |
Whats driving growth Growth driven by demand in pharma and nutrition sectors, new battery materials segment, strategic acquisitions, and capacity expansions. |
Our future plans Commission new greenfield manufacturing facility in 2026; establish battery chemicals plant in Dahej by 2027; strengthen global footprint via acquisitions. |
Our green promise Focus on sustainable manufacturing and green technology for battery materials; details on ESG initiatives not specified. |
Our people and values Over 700 employees with a diverse workforce; strong focus on safety, inclusion, and employee development policies. |
Key challenges ahead Navigating regulatory compliance globally, supply chain diversification, emerging competition, and managing expansion capital expenditures. |
Interesting facts First Indian company with US FDA approval for mineral-based ingredients; among top global producers of iron phosphate; pioneer in liposomal ingredients. |
Risks and strategy Mitigates risks with diversified product portfolio, regulatory certifications, in-house R&D, and strategic market diversification. |
